Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, MD, USA.
Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, MD, USA.
Value Health. 2014 Jun;17(4):471-5. doi: 10.1016/j.jval.2014.02.012. Epub 2014 May 5.
Evidence from clinical trials should contribute to informed decision making and a learning health care system. People frequently, however, find participating in clinical trials meaningless or disempowering. Moreover, people often do not incorporate trial results directly into their decision making. The lack of patient centeredness in clinical trials may be partially addressed through trial design. For example, Bayesian adaptive trials designed to adjust in a prespecified manner to changes in clinical practice could motivate people and their health care providers to view clinical trials as more applicable to real-world clinical decisions. The way in which clinical trials are designed can transform the evidence generation process to be more patient centered, providing people with an incentive to participate or continue participating in clinical trials. To achieve the transformation to patient-centeredness in clinical trial decisions, however, there is a need for transparent and reliable methods and education of trial investigators and site personnel.
来自临床试验的证据应该有助于做出明智的决策和建立学习型医疗保健系统。然而,人们经常发现参与临床试验没有意义或没有赋予权力。此外,人们通常不会直接将试验结果纳入其决策中。临床试验中缺乏以患者为中心的方法可能可以通过试验设计部分解决。例如,贝叶斯适应性试验旨在以预定的方式根据临床实践的变化进行调整,这可以激励人们及其医疗保健提供者将临床试验视为更适用于现实世界临床决策的方法。临床试验的设计方式可以将证据生成过程转变为更加以患者为中心,为人们参与或继续参与临床试验提供动力。然而,要实现临床试验决策的以患者为中心的转变,需要有透明和可靠的方法以及对试验研究者和现场人员的教育。